156 related articles for article (PubMed ID: 21971701)
1. Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis.
Qureshi A; Wray D; Rhome R; Barry W; Del Poeta M
Mycopathologia; 2012 Jun; 173(5-6):419-25. PubMed ID: 21971701
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.
Jalali Z; Ng L; Singh N; Pirofski LA
Clin Vaccine Immunol; 2006 Jul; 13(7):740-6. PubMed ID: 16829610
[TBL] [Abstract][Full Text] [Related]
3. Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA).
Santangelo RT; Chen SC; Sorrell TC; Wright LC
Med Mycol; 2005 Jun; 43(4):335-41. PubMed ID: 16110779
[TBL] [Abstract][Full Text] [Related]
4. Novel recombinant multiepitope proteins for the detection of anti-Cryptococcus antibodies.
de Serpa Brandão RMS; Faria AR; de Andrade HM; Soares Martins LM; da Silva AS; do Monte SJH
Future Microbiol; 2018 Mar; 13():429-436. PubMed ID: 29125786
[TBL] [Abstract][Full Text] [Related]
5. A Spuriously Negative Cryptococcal Antigen Assay Result in Disseminated Cryptococcosis: the Deception of the Postzone Phenomenon.
Malik AAA; Periyasamy P; Kori N; Wahab AA; Ding CH
Ann Clin Lab Sci; 2021 May; 51(3):430-433. PubMed ID: 34162576
[No Abstract] [Full Text] [Related]
6. Clinical Significance of Low Serum Cryptococcal Antigen Titers by Lateral Flow Assay in Immunocompromised Patients: a Retrospective Case-Control Study.
Dizon E; Seo W; Butler-Wu SM; She RC
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723013
[No Abstract] [Full Text] [Related]
7. Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV-Related Cryptococcosis.
Jitmuang A; Panackal AA; Williamson PR; Bennett JE; Dekker JP; Zelazny AM
J Clin Microbiol; 2016 Feb; 54(2):460-3. PubMed ID: 26607986
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia.
Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.
McMullan BJ; Halliday C; Sorrell TC; Judd D; Sleiman S; Marriott D; Olma T; Chen SC
PLoS One; 2012; 7(11):e49541. PubMed ID: 23166705
[TBL] [Abstract][Full Text] [Related]
10. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
Abadi J; Pirofski La
J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia.
Escandón P; Lizarazo J; Agudelo CI; Chiller T; Castañeda E
Med Mycol; 2013 Oct; 51(7):765-8. PubMed ID: 23611420
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.
Rodrigues ML; Shi L; Barreto-Bergter E; Nimrichter L; Farias SE; Rodrigues EG; Travassos LR; Nosanchuk JD
Clin Vaccine Immunol; 2007 Oct; 14(10):1372-6. PubMed ID: 17715331
[TBL] [Abstract][Full Text] [Related]
13. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
14. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
[TBL] [Abstract][Full Text] [Related]
15. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
Chai HC; Tay ST
Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
[TBL] [Abstract][Full Text] [Related]
16. Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV.
Medina N; Alastruey-Izquierdo A; Mercado D; Bonilla O; Pérez JC; Aguirre L; Samayoa B; Arathoon E; Denning DW; Rodriguez-Tudela JL;
AIDS; 2020 Sep; 34(11):1625-1632. PubMed ID: 32694415
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus antigens and immune responses: implications for a vaccine.
Chaturvedi AK; Wormley FL
Expert Rev Vaccines; 2013 Nov; 12(11):1261-72. PubMed ID: 24156284
[TBL] [Abstract][Full Text] [Related]
18. The Eiken Latex test for detection of a cryptococcal antigen in cryptococcosis. Comparison with a monoclonal antibody-based latex agglutination test, Pastorex Cryptococcus.
Tanaka K; Kohno S; Miyazaki T; Miyazaki H; Mitsutake K; Maesaki S; Kaku M; Koga H
Mycopathologia; 1994 Sep; 127(3):131-4. PubMed ID: 7808506
[TBL] [Abstract][Full Text] [Related]
19. [A prospective multi-center clinical investigation of HIV-negative pulmonary cryptococcosis in China].
Chen LA; She DY; Liang ZX; Liang LL; Chen RC; Ye F; Li YP; Zhou Y; Chen XH; Fang SF; Lai GX; Hu Q; Xie BS; Yao XJ; Shi Y; Su X; He LX; Zhou JY; Zhong SC; Zhang QL; Xiong SD; Qu JM; Tong ZH; Jiang SJ; Liu J; Xu F; He B; Li ER; Yuan YD; Zhang XY; Sun TY; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Jan; 44(1):14-27. PubMed ID: 33412620
[No Abstract] [Full Text] [Related]
20. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
